Family‐based Helicobacter pylori infection control and management strategy and screen‐and‐treat strategy are highly cost‐effective in preventing multiple upper gastrointestinal diseases in Chinese population at national level

Author:

Zhang Chen1,Qi Ya‐Bin2,Hu Ruo‐Bing2,Xu Lu2,Li Xiao‐Ting2,Ma Jing2,Shao Qiao‐Qiao2,Abdun Mohammed Awadh2,Ur Rahman Ishtiaq2,Shi Wen‐Jun3,Li Fu‐Qiang3,Yu Jian‐Jie3,Yuan Ming‐Kai3,Chen Qi4ORCID,Lu Hong5ORCID,Ding Song‐Ze12

Affiliation:

1. Department of Gastroenterology and Hepatology Henan University People's Hospital, and Henan Provincial People's Hospital Zhengzhou China

2. Department of Gastroenterology and Hepatology People's Hospital of Zhengzhou University, and Henan Provincial People's Hospital Zhengzhou China

3. Department of Gastroenterology and Hepatology Huangchuan People's Hospital Huangchuan China

4. Department of Gastroenterology and Hepatology, Zhongshan Hospital Fudan University Shanghai China

5. Department of Gastroenterology and Hepatology, Key Laboratory of Gastroenterology & Hepatology, Ministry of Health, Renji Hospital, School of Medicine, Shanghai Institute of Digestive Disease Shanghai Jiao Tong University Shanghai China

Abstract

AbstractBackgroundThe overall benefits of the newly introduced family‐based Helicobacter pylori (H. pylori) infection control and management (FBCM) and screen‐and‐treat strategies in preventing multiple upper gastrointestinal diseases at national level in China have not been explored. We investigate the cost‐effectiveness of these strategies in the whole Chinese population.Materials and MethodsDecision trees and Markov models of H. pylori infection‐related non‐ulcer dyspepsia (NUD), peptic ulcer disease (PUD), and gastric cancer (GC) were developed to simulate the cost‐effectiveness of these strategies in the whole 494 million households in China. The main outcomes include cost‐effectiveness, life years (LY), quality‐adjusted life year (QALY), and incremental cost‐effectiveness ratio (ICER).ResultsWhen compared with no‐screen strategy, both FBCM and screen‐and‐treat strategies reduced the number of new cases of NUD, PUD, PUD‐related deaths, and the prevalence of GC, and cancer‐related deaths. The costs saved by these two strategies were $1467 million and $879 million, quality‐adjusted life years gained were 227 million and 267 million, and life years gained were 59 million and 69 million, respectively. Cost‐effectiveness analysis showed that FBCM strategy costs −$6.46/QALY and −$24.75/LY, and screen‐and‐treat strategy costs −$3.3/QALY and −$12.71/LY when compared with no‐screen strategy. Compared to the FBCM strategy, the screen‐and‐treat strategy reduced the incidence of H. pylori‐related diseases, added 40 million QALYs, and saved 10 million LYs, but at the increased cost of $588 million. Cost‐effectiveness analysis showed that screen‐and‐treat strategy costs $14.88/QALY and $59.5/LY when compared with FBCM strategy. The robustness of the results was also verified.ConclusionsBoth FBCM and screen‐and‐treat strategies are highly cost‐effective in preventing NUD, PUD, and GC than the no‐screen strategy in Chinese families at national level. As FBCM strategy is more practical and efficient, it is expected to play a more important role in preventing familial H. pylori infection and also serves as an excellent reference for other highly infected societies.

Funder

National Natural Science Foundation of China

Health Commission of Henan Province

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3